Skip Navigation


NDT Advance Access originally published online on January 4, 2008
Nephrology Dialysis Transplantation 2008 23(7):2356-2364; doi:10.1093/ndt/gfm921
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
23/7/2356    most recent
gfm921v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Oh, K.-H.
Right arrow Articles by Ahn, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oh, K.-H.
Right arrow Articles by Ahn, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.For Permissions, please e-mail: journals.permissions@oxfordjournals.org



Baseline peritoneal solute transport rate is not associated with markers of systemic inflammation or comorbidity in incident Korean peritoneal dialysis patients

Kook-Hwan Oh1, Ju-Young Moon1, Jieun Oh2, Seong Gyun Kim3, Young-Hwan Hwang1, Suhnggwon Kim1, Jung Sang Lee1 and Curie Ahn4,5,6

1 Department of Internal Medicine, Seoul National University Hospital 2 Department of Medicine, Hallym University 3 Department of Internal Medicine & Kidney Research Institute, Hallym University College of Medicine 4 Department of Internal Medicine, Seoul National University Hospital 5 Transplantation Research Institute 6 Cancer Research Institute, Seoul National University, Seoul, Korea

Correspondence and offprint requests to: Curie Ahn, Department of Internal Medicine, Seoul National University Hospital, Chongno Gu, 110-744, Seoul, Korea. Tel: +82-2-2072-2222; Fax: +82-2-741-4876; E-mail: curie{at}snu.ac.kr



  Abstract

Background. It is controversial whether comorbid status or systemic inflammation has an influence on the peritoneal solute transport rate (PSTR). Our aim is to elucidate whether baseline PSTR is associated with markers of systemic inflammation or degree of comorbidity in incident peritoneal dialysis (PD) patients.

Methods. One hundred and ninety-five incident PD patients were prospectively included. Results of their baseline peritoneal equilibration test (PET) using 3.86% glucose PD fluid were analysed. Clinical and laboratory parameters of inflammation, comorbidity, nutritional status, dialysis adequacy and residual renal function (RRF) were assessed at the time of PET.

Results. Mean dialysate-to-plasma ratio for creatinine at 4 h (D/Pcr4) of our patients was 0.72 ± 0.11. High-sensitivity C-reactive protein (hsCRP), serum interleukin-6 (IL-6) and serum albumin concentrations were closely interrelated to one another and these markers of systemic inflammation were also related to the Davies comorbidity score. No differences in age, sex ratio, body mass index, body surface area and presence of diabetes were found among four transport groups. RRF, total Kt/V, haemoglobin, nitrogen appearance and the Davies comorbidity score were not different either. High-sensitivity CRP, serum IL-6 and albumin concentrations were not associated with the baseline PSTR. By multiple linear regression analysis, only the serum albumin concentration measured at the time of PET (β = –0.081 ± 0.020, P < 0.001) remained significantly associated with D/Pcr4.

Conclusion. In our study with incident Korean PD patients, the baseline PSTR was not influenced by markers of systemic inflammation or comorbidity. For a subgroup of PD patients without serious comorbidity, other mechanisms of high baseline PSTR need to be elucidated.

Keywords: comorbidity; inflammation; interleukin-6; peritoneal solute transport

Received for publication: 3. 8.07
Accepted in revised form: 7.12.07


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
S. Kim, J. Oh, S. Kim, W. Chung, C. Ahn, S. G. Kim, and K.-H. Oh
Benefits of biocompatible PD fluid for preservation of residual renal function in incident CAPD patients: a 1-year study
Nephrol. Dial. Transplant., September 1, 2009; 24(9): 2899 - 2908.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
A. Davenport and M. K. Willicombe
Hydration Status Does Not Influence Peritoneal Equilibration Test Ultrafiltration Volumes
Clin. J. Am. Soc. Nephrol., July 1, 2009; 4(7): 1207 - 1212.
[Abstract] [Full Text] [PDF]


Home page
pdiHome page
Y.-L. Kim
UPDATE ON MECHANISMS OF ULTRAFILTRATION FAILURE
Perit. Dial. Int., February 1, 2009; 29(Supplement_2): S123 - S127.
[Abstract] [Full Text] [PDF]


Home page
pdiHome page
Y.-H. Hwang, M.-J. Son, J. Yang, K. Kim, W. Chung, K.-W. Joo, Y. Kim, C. Ahn, and K.-H. Oh
EFFECTS OF INTERLEUKIN-6 T15A SINGLE NUCLEOTIDE POLYMORPHISM ON BASELINE PERITONEAL SOLUTE TRANSPORT RATE IN INCIDENT PERITONEAL DIALYSIS PATIENTS
Perit. Dial. Int., January 1, 2009; 29(1): 81 - 88.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.